Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_869620724535c26b3e814325a37a5104 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-42 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-02 |
filingDate |
2013-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c17f84308fdbd7fc4f1dd0d263114b46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd3887e755046425a4f561fe22fec8fb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a59a6fcb3bee4f7cae85691b20faab3b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e39ef50902d58702bc12437bd778cafd |
publicationDate |
2014-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8765947-B2 |
titleOfInvention |
Preparation method of Rosuvastatin calcium and its intermediates |
abstract |
A preparation method of rosuvastatin calcium (Formula 1), which can be used for the production of medicament lowering the levels of LDL-cholesterol and triglycerides in vivo, is provided. Such preparation method is suitable for industrial production. Furthermore, the intermediate crystallines used in the preparation method are provided. |
priorityDate |
2008-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |